Literature DB >> 6975183

Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania.

K J Towner, N J Pearson, F S Mhalu, F O'Grady.   

Abstract

Isolates of Vibrio cholerae obtained immediately after the outbreak of the fourth recorded epidemic of cholera in the United Republic of Tanzania were sensitive to tetracycline, but after five months of its extensive therapeutic and prophylactic use, 76% of the isolates were observed to be resistant to this and other antimicrobial agents. The appearance of resistance was found to be due to the rapid spread of antibiotic resistance plasmids belonging to the C incompatibility complex. Although most plasmid incompatibility groups have been shown to be unstable in V. cholerae, the strains found in the present epidemic seem to carry a plasmid belonging to one of the few relatively stable groups. These findings emphasize the importance of monitoring any emergence of bacterial resistance that may occur when mass prophylaxis programmes are in operation and also the importance of determining the genetic basis of the resistance mechanism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6975183      PMCID: PMC2395989     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  A 98 megadalton R factor of compatibility group C in a Vibrio cholerae El Tor isolate from southern U.S.S.R.

Authors:  R W Hedges; A E Jacob
Journal:  J Gen Microbiol       Date:  1975-08

Review 2.  Pedigrees of some mutant strains of Escherichia coli K-12.

Authors:  B J Bachmann
Journal:  Bacteriol Rev       Date:  1972-12

3.  General method for the isolation of plasmid deoxyribonucleic acid.

Authors:  P Guerry; D J LeBlanc; S Falkow
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

4.  Phosphonopeptides as antibacterial agents: rationale, chemistry, and structure-activity relationships.

Authors:  F R Atherton; M J Hall; C H Hassall; R W Lambert; P S Ringrose
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

5.  Trimethoprim R plasmids isolated during long-term treatment of urinary tract infection with co-trimoxazole.

Authors:  K J Towner; N J Pearson; W R Cattell; F O'Grady
Journal:  J Antimicrob Chemother       Date:  1979-01       Impact factor: 5.790

6.  Global surveillance of antibiotic sensitivity of Vibrio cholerae.

Authors:  F O'Grady; M J Lewis; N J Pearson
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

7.  Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.

Authors:  A E Jacob; S J Hobbs
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

8.  Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides.

Authors:  J G Allen; F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; L J Nisbet; P S Ringrose
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

9.  Comparison of the deoxyribonucleic acid molecular weights and homologies of plasmids conferring linked resistance to streptomycin and sulfonamides.

Authors:  P T Barth; N J Grinter
Journal:  J Bacteriol       Date:  1974-11       Impact factor: 3.490

10.  R plasmids from Asian strains of Vibrio cholerae.

Authors:  R W Hedges; J L Vialard; N J Pearson; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

  10 in total
  18 in total

1.  Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers.

Authors:  Amber Kunkel; Joseph A Lewnard; Virginia E Pitzer; Ted Cohen
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

2.  Vibrio cholerae serogroup O1 in northeast Thailand.

Authors:  T Kuyyakanond; S Nakamura; W Manmontri; M Iwanaga
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

3.  Single dose tetracycline in cholera.

Authors:  M R Islam
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

4.  The prevalence and genetics of resistance to commonly used antimicrobial agents in faecal Enterobacteriaceae from children in Bangladesh.

Authors:  K Z Mamun; P Shears; C A Hart
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

Review 5.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

6.  Vibrio cholerae O1 isolated in Kenya.

Authors:  M Iwanaga; K Mori; J N Kaviti
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

7.  Molecular evidence of cholera outbreak caused by a toxigenic Vibrio cholerae O1 El tor variant strain in Kelantan, Malaysia.

Authors:  Geik Yong Ang; Choo Yee Yu; Kamarudin Balqis; Husni Tan Elina; Hussin Azura; Mat Hussin Hani; Chan Yean Yean
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

8.  Clinical outcomes in household contacts of patients with cholera in Bangladesh.

Authors:  Ana A Weil; Ashraful I Khan; Fahima Chowdhury; Regina C Larocque; A S G Faruque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

9.  Spatial clustering of cholera cases in the Kathmandu Valley: implications for a ring vaccination strategy.

Authors:  Mellisa Roskosky; Mohammad Ali; Shyam Raj Upreti; David Sack
Journal:  Int Health       Date:  2021-02-24       Impact factor: 2.473

10.  Guanosine tetra- and pentaphosphate increase antibiotic tolerance by reducing reactive oxygen species production in Vibrio cholerae.

Authors:  Hwa Young Kim; Junhyeok Go; Kang-Mu Lee; Young Taek Oh; Sang Sun Yoon
Journal:  J Biol Chem       Date:  2018-02-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.